Digital follow-up program for COPD patients in primary healthcare

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to empower individuals with Chronic Obstructive Pulmonary Disease (COPD) through a digital platform that facilitates guided self-determination (GSD) follow-ups by primary care nurses. The intervention focuses on enhancing self-management skills and improving the quality of life for patients living with COPD. By integrating digital home-based care within a general practice setting, the study explores the feasibility of this approach in primary healthcare. The goal is to address the challenges faced by COPD patients and contribute to a sustainable healthcare system.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with COPD living at home
* Post-bronchodilator forced expiratory volume 1 s (FEV1) to forced vital capacity (FVC) below lower limit of normality

Exclusion Criteria:

* Severe somatic disease
* Severe psychiatric diagnosis
* Not able to provide informed consent
* Do not write, speak or understand Norwegian

Where it's running

• Western Norway University of Applied Sciences
  Bergen, Norway, Norway Recruiting

Study contacts

• Principal investigator: Beate-Christin H Kolltveit, Ph.D. — Western Norway University of Applied Sciences
• Study coordinator: Beate-Christin H Kolltveit, Ph.D.
• Email: beate-christin.hope.kolltveit@hvl.no
• Phone: +47 41206108

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enhanced COPD care for people being checked for lung cancer

  This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.

  Recruiting Region of Southern Denmark · Vejle · NCT07543601

• High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia

  This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.

  Recruiting Mansoura University · Al Mansurah, Dakahlia Governorate · NCT07854210

• Risk-based lung cancer screening in COPD patients using ML and clinical models

  This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.

  Recruiting Vejle Hospital · Vejle, Region Syddanmark · NCT07848815

• Biologics for Type 2 Inflammation in Asthma and COPD in Real World

  This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07823842

• Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers

  This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.

  Recruiting at 2 sites Phase 4 COPD Foundation · Saint Charles, Missouri and 1 other locations · NCT07816835

• New breathing tests to diagnose airway disease in hospital and community settings

  This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.

  Recruiting University Hospital Southampton NHS Foundation Trust · Andover, Hampshire and 1 other locations · NCT07798596

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.